14(R,S)-[18F]Fluoro-6-thia-heptadecanoic acid as a tracer of free fatty acid uptake and oxidation in myocardium and skeletal muscle.
14( R, S)-[(18)F]Fluoro-6-thia-heptadecanoic acid ([(18)F]FTHA) is a long-chain fatty acid substrate for fatty acid metabolism. [(18)F]FTHA has been used to study fatty acid metabolism in human heart and skeletal muscle. It has been suggested that the rate of radioactivity accumulation in the myocardium reflects the beta-oxidation rate of free fatty acids (FFAs). However, the net accumulation of FFAs in tissue always represents the sum of FFA oxidation and incorporation into triglycerides. The fraction of [(18)F]FTHA entering directly into mitochondria for oxidation has not been previously measured. Eight anaesthetized pigs were studied with [(18)F]FTHA and positron emission tomography (PET). Immediately after each PET experiment, tissue samples from myocardium and skeletal muscle were taken for the isolation of mitochondria and measurements of radioactivity accumulation, and for intracellular [(18)F]FTHA metabolite analysis. Fractional [(18)F]FTHA uptake rates were calculated both by graphical analysis of PET data and by measuring (18)F in the tissue samples. Fractional [(18)F]FTHA uptake rates based on the analysis of tissue samples were 0.56+/-0.17 ml g(-1) min(-1) and 0.037+/-0.007 ml g(-1) min(-1) for myocardium and skeletal muscle (mean +/- SD), respectively. The myocardial results obtained from the PET data (0.50+/-0.11 ml g(-1) min(-1)) were similar to the values obtained from the tissue samples ( r=0.94, P=0.002). We also found that 89%+/-23% (mean+/-SD, n=7) of the (18)F entered mitochondria in myocardium, as compared with only 36%+/-15% (mean+/-SD, n=7) in skeletal muscle. Intracellular [(18)F]FTHA metabolite analysis showed that a major part of [(18)F]FTHA is metabolized in the mitochondria in the heart. Our data suggest that ~89% of [(18)F]FTHA taken up by the heart enters mitochondria. This supports the hypothesis that [(18)F]FTHA traces FFA beta-oxidation in the heart. In contrast to this, only ~36% of [(18)F]FTHA accumulated in skeletal muscle appears to directly enter mitochondria; the majority is taken up by the other cell fractions, suggesting that in skeletal muscle [(18)F]FTHA traces FFA uptake but not specifically FFA beta-oxidation.
Takala
Teemu O
TO
Turku PET Centre, Turku University Central Hospital, PO Box 52, 20521 Turku, Finland.
Nuutila
Pirjo
P
Pulkki
Kari
K
Oikonen
Vesa
V
Grönroos
Tove
T
Savunen
Timo
T
Vähäsilta
Tommi
T
Luotolahti
Matti
M
Kallajoki
Markku
M
Bergman
Jörgen
J
Forsback
Sarita
S
Knuuti
Juhani
J
D000818:Animals; D005227:Fatty Acids / Q000493:pharmacokinetics*; D005230:Fatty Acids, Nonesterified / Q000378:metabolism / Q000493:pharmacokinetics*; D006352:Heart Ventricles / Q000000981:diagnostic imaging / Q000378:metabolism; D008657:Metabolic Clearance Rate; D008929:Mitochondria, Heart / Q000000981:diagnostic imaging / Q000378:metabolism*; D008931:Mitochondria, Muscle / Q000000981:diagnostic imaging / Q000378:metabolism*; D018482:Muscle, Skeletal / Q000000981:diagnostic imaging / Q000378:metabolism; D009206:Myocardium / Q000378:metabolism*; D010084:Oxidation-Reduction; D019275:Radiopharmaceuticals / Q000493:pharmacokinetics; D013552:Swine; D013848:Thigh / Q000000981:diagnostic imaging; D014018:Tissue Distribution; D014055:Tomography, Emission-Computed
D005227:Fatty Acids; D005230:Fatty Acids, Nonesterified; D019275:Radiopharmaceuticals; C071178:14-fluoro-6-thiaheptadecanoic acid